Immersive Virtual Reality Exposure Associated With a Migraine With Brainstem Aura-Like Presentation and Prolonged Recovery: A Case Report.
- 1Faculty of Medicine and Life Sciences University of Latvia Riga Latvia.
- 2Faculty of Medicine Homs University Homs Syrian Arab Republic.
Abstract
Immersive virtual reality (VR) exposure can produce a range of neurological symptoms, but its possible relationship with prolonged migraine-related symptoms remains poorly characterized. We report a 32-year-old male who developed acute disorientation, vertigo, cognitive clouding, derealization, and sensory disturbances immediately following a 30-min immersive VR session. Symptoms partially improved but recurred with sensory overstimulation the following day. Despite unremarkable neuro-otological examinations, the patient experienced a markedly atypical, two-week period of persistent neurological symptoms featuring hypersomnia, cognitive fatigue, and sensory hypersensitivity. The presentation was considered a migraine with brainstem aura-like presentation, although it did not fulfill ICHD-3 criteria for definite migraine with brainstem aura. Symptoms gradually resolved completely by approximately 2 weeks, with no recurrence reported at the 3- and 6-month follow-ups. This case describes a temporal association between immersive VR exposure and a prolonged migraine-like neurological presentation, highlighting the need for clinical awareness of symptoms occurring after immersive digital exposure.
Related
- Bickerstaff Brainstem Encephalitis with a Decorticate-like Posture, Involuntary Movements, Impaired Visual Acuity, and Prolonged Motor Disability
- Altered lower brainstem neurophysiological response is associated with mortality in deeply sedated critically ill patients
- Training community providers in prolonged exposure: outcomes of a French consultation programme.
- Primary pulmonary small cell carcinoma in a 13-year-old boy with prolonged second-hand tobacco smoke exposure: A rare pediatric lung malignancy with a review of reported cases and registry data.
- Cefepime exposure in prolonged or intermittent infusion in critically ill children
BibTeX
@article{aldawoudi2026immersive,
title = {{Immersive Virtual Reality Exposure Associated With a Migraine With Brainstem Aura-Like Presentation and Prolonged Recovery: A Case Report.}},
author = {Abdulrahman Al-Dawoudi and Daniil Varlamov and Shaghaf Alhallak and Mujahed Dalain},
journal = {Clinical case reports},
year = {2026},
month = nov,
doi = {10.1002/ccr3.73895},
url = {https://europepmc.org/article/MED/42997322},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Immersive Virtual Reality Exposure Associated With a Migraine With Brainstem Aura-Like Presentation and Prolonged Recovery: A Case Report.
AU - Abdulrahman Al-Dawoudi
AU - Daniil Varlamov
AU - Shaghaf Alhallak
AU - Mujahed Dalain
PY - 2026
DA - 2026/11/06
JO - Clinical case reports
DO - 10.1002/ccr3.73895
UR - https://europepmc.org/article/MED/42997322
AB - Immersive virtual reality (VR) exposure can produce a range of neurological symptoms, but its possible relationship with prolonged migraine-related symptoms remains poorly characterized. We report a 32-year-old male who developed acute disorientation, vertigo, cognitive clouding, derealization, and sensory disturbances immediately following a 30-min immersive VR session. Symptoms partially improved but recurred with sensory overstimulation the following day. Despite unremarkable neuro-otological examinations, the patient experienced a markedly atypical, two-week period of persistent neurological symptoms featuring hypersomnia, cognitive fatigue, and sensory hypersensitivity. The presentation was considered a migraine with brainstem aura-like presentation, although it did not fulfill ICHD-3 criteria for definite migraine with brainstem aura. Symptoms gradually resolved completely by approximately 2 weeks, with no recurrence reported at the 3- and 6-month follow-ups. This case describes a temporal association between immersive VR exposure and a prolonged migraine-like neurological presentation, highlighting the need for clinical awareness of symptoms occurring after immersive digital exposure.
SN - 2050-0904
ER -